Jay Koyner to Clinical Trials as Topic
This is a "connection" page, showing publications Jay Koyner has written about Clinical Trials as Topic.
Connection Strength
0.373
-
Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement. Intensive Care Med. 2024 Sep; 50(9):1426-1437.
Score: 0.161
-
Have biomarkers failed in acute kidney injury? No. Intensive Care Med. 2017 06; 43(6):887-889.
Score: 0.097
-
Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury? Nephron Exp Nephrol. 2008; 109(4):e109-17.
Score: 0.054
-
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials. Crit Care. 2024 03 21; 28(1):92.
Score: 0.039
-
Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment. Am J Kidney Dis. 2016 07; 68(1):19-28.
Score: 0.022